Thrombocytopenia
230
22
25
117
Key Insights
Highlights
Success Rate
79% trial completion
Published Results
54 trials with published results (23%)
Research Maturity
117 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
13.5%
31 terminated out of 230 trials
79.1%
-7.5% vs benchmark
17%
39 trials in Phase 3/4
46%
54 of 117 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 117 completed trials
Clinical Trials (230)
Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion
Efficacy and Safety of MegaLT Injection for Platelet Recovery After Umbilical Cord Blood Transplantation
EFFECT OF PLATELET CONCENTRATE TRANSFUSION ON MICROCIRCULATORY ENDOTHELIAL FUNCTION IN INTENSIVE CARE UNIT
Romiplostim in Thoracic Transplantation
Role of Viscoelastometric Testing in the Development and Validation of a Clinical-biological Score for Predicting Bleeding in Patients With Malignant Haematological Disorders and Severe Thrombocytopenia
Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis
Prediction of Platelet Function Using Viscoelastic Test (ROTEM® Sigma) in Obstetric Anesthesia.
Collection of the Thrombo-VaxCov Cohort
Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger
Managed Access Programs for ETB115, Eltrombopag
Apixaban in Thrombocytopenia
Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma
Neonatal Platelet Transfusion Threshold Trial
Luspatercept for Clonal Cytopenias of Uncertain Significance
A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients
Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT
STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis
Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed State